XyloCor Therapeutics (Venture Capital)

Funding Details
Awarder
Inbox
Date Award
May 27, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Company Description
XyloCor Therapeutics is focused on developing innovative gene therapies for the treatment of cardiovascular diseases. The company utilizes proprietary technology to deliver therapeutic genes directly to the heart, aiming to improve patient outcomes.
Market
Therapeutics
Location
USA

Links